ArticleCurrent protocols2025

Middle-Down Nuclear Magnetic Resonance for Therapeutic Monoclonal Antibody Glycan Profiling.

Jiayi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.